EPRX Eupraxia Pharmaceuticals Inc. - Common Stock
$6,93
Harga · Agu 19, 2026
Rentang 52M
$5–$9
46% of range
Peringkat Analis
BUY
11 analysts
Target Harga
$16
+136% upside
P/E (TTM)
—
ROE
—
Margin Laba Bersih
—
EPRX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$6.92
Kapitalisasi Pasar
—
P/E (TTM)
—
EPS (TTM)
—
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
—
D/E Utang/Ekuitas
—
Rentang 52M
$5 – $9
EPRX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
—
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
EPRX
Median Rekan
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
EPRX
Median Rekan
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
EPRX
Median Rekan
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
EPRX
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
EPRX
Median Rekan
EPRX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
11 analis
- Beli Kuat 4 36,4%
- Beli 6 54,5%
- Tahan 1 9,1%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
10 analis · 2026-08-15
Median
$15.75
← Di bawah semua target
$6.92
Rendah
$11.00
Tinggi
$25.00
Target median
$15.75
+127,4%
Target rata-rata
$16.35
+136,1%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.07%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 31 Maret 2026 | $-0.23 | $-0.23 | -0.00% |
| 31 Des. 2025 | $-0.37 | $-0.17 | -0.20% |
| 30 Sep. 2025 | $-0.19 | $-0.16 | -0.03% |
| 30 Juni 2025 | $-0.26 | $-0.19 | -0.07% |
| 31 Maret 2025 | $-0.21 | $-0.17 | -0.04% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| EPRX | — | — | — | — | — | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
| AUPH | $2.11B | 7.7 | 20.4% | 101.5% | 62.7% | — |
| ABUS | $926M | -28.3 | 128.2% | -237.9% | -42.0% | — |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| ACOG | $141M | -5.5 | — | -202.2% | -43.8% | — |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 66 pengaju · $123.8M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 18 (-3 vs Kuartal sebelumnya) | 5 (+2 vs Kuartal sebelumnya) | 20 (+1 vs Kuartal sebelumnya) | 17 (+11 vs Kuartal sebelumnya) | +2.0M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Affinity Asset Advisors, LLC | $10.906.500 | 1.650.000 | 8,81% | Saham |
| Balyasny Asset Management L.P. | $8.923.599 | 1.350.015 | 7,21% | Saham |
| Vivo Capital, LLC | $8.923.500 | 1.350.000 | 7,21% | Saham |
| SCOTIA CAPITAL INC. | $8.782.272 | 1.343.726 | 7,10% | Saham |
| PFM Health Sciences, LP | $8.002.469 | 1.210.661 | 6,47% | Saham |
| GREAT POINT PARTNERS LLC | $7.932.000 | 1.200.000 | 6,41% | Saham |
| Rubric Capital Management LP | $5.733.673 | 867.424 | 4,63% | Saham |
| Ikarian Capital, LLC | $5.352.388 | 809.741 | 4,32% | Saham |
| Woodline Partners LP | $4.936.771 | 746.864 | 3,99% | Saham |
| Point72 Asset Management, L.P. | $4.827.716 | 730.284 | 3,90% | Saham |
| AMERIPRISE FINANCIAL INC | $4.699.869 | 711.024 | 3,80% | Saham |
| Redmile Group, LLC | $4.041.354 | 611.400 | 3,27% | Saham |
| MILLENNIUM MANAGEMENT LLC | $2.918.796 | 441.586 | 2,36% | Saham |
| CITADEL ADVISORS LLC | $2.674.452 | 404.607 | 2,16% | Saham |
| Alyeska Investment Group, L.P. | $2.478.750 | 375.000 | 2,00% | Saham |
| PICTON MAHONEY ASSET MANAGEMENT | $2.385.404 | 360.878 | 1,93% | Saham |
| Velan Capital Investment Management LP | $2.326.720 | 352.000 | 1,88% | Saham |
| Seven Fleet Capital Management LP | $2.212.929 | 334.785 | 1,79% | Saham |
| Aisling Capital Management LP | $2.148.250 | 325.000 | 1,74% | Saham |
| SummitTX Capital, L.P. | $2.107.162 | 318.784 | 1,70% | Saham |
| ROYAL BANK OF CANADA | $2.045.000 | 309.400 | 1,65% | Saham |
| DV EQUITIES, LLC | $1.824.360 | 276.000 | 1,47% | Saham |
| ORBIMED ADVISORS LLC | $1.778.090 | 269.000 | 1,44% | Saham |
| BANK OF AMERICA CORP /DE/ | $1.749.806 | 264.721 | 1,41% | Saham |
| Ally Bridge Group (NY) LLC | $1.666.877 | 252.175 | 1,35% | Saham |
| CIBC WORLD MARKET INC. | $1.539.137 | 234.673 | 1,24% | Saham |
| DAFNA Capital Management LLC | $1.491.216 | 225.600 | 1,20% | Saham |
| TWO SIGMA INVESTMENTS, LP | $1.461.365 | 221.084 | 1,18% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.405.636 | 212.653 | 1,14% | Saham |
| JANE STREET GROUP, LLC | $1.208.037 | 184.203 | 0,98% | Saham |
| TD Waterhouse Canada Inc. | $534.915 | 79.607 | 0,43% | Saham |
| XTX Topco Ltd | $464.452 | 70.265 | 0,38% | Saham |
| Annis Gardner Whiting Capital Advisors, LLC | $396.600 | 60.000 | 0,32% | Saham |
| GOLDMAN SACHS GROUP INC | $383.763 | 58.058 | 0,31% | Saham |
| 1832 Asset Management L.P. | $333.356 | 50.432 | 0,27% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $305.018 | 46.145 | 0,25% | Saham |
| Stonepine Capital Management, LLC | $287.476 | 43.491 | 0,23% | Saham |
| BANK OF MONTREAL /CAN/ | $252.195 | 38.457 | 0,20% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $239.354 | 36.211 | 0,19% | Saham |
| UBS Group AG | $234.648 | 35.499 | 0,19% | Saham |
| Brevan Howard Capital Management LP | $229.810 | 34.767 | 0,19% | Saham |
| Qube Research & Technologies Ltd | $226.307 | 34.237 | 0,18% | Saham |
| MARSHALL WACE, LLP | $151.904 | 22.981 | 0,12% | Saham |
| AXQ CAPITAL, LP | $139.802 | 21.150 | 0,11% | Saham |
| Jump Financial, LLC | $130.878 | 19.800 | 0,11% | Saham |
| NATIXIS | $115.215 | 17.644 | 0,09% | Saham |
| JPMORGAN CHASE & CO | $93.486 | 14.186 | 0,08% | Saham |
| China Universal Asset Management Co., Ltd. | $82.625 | 12.500 | 0,07% | Saham |
| RAYMOND JAMES FINANCIAL INC | $80.774 | 12.220 | 0,07% | Saham |
| TCI Wealth Advisors, Inc. | $72.710 | 11.000 | 0,06% | Saham |
| GUARDIAN WEALTH ADVISORS, LLC / NC | $69.405 | 10.500 | 0,06% | Saham |
| Aptus Capital Advisors, LLC | $69.405 | 10.500 | 0,06% | Saham |
| Lynx1 Capital Management LP | $66.100 | 10.000 | 0,05% | Saham |
| Shay Capital LLC | $66.100 | 10.000 | 0,05% | Saham |
| Integrated Wealth Concepts LLC | $65.274 | 9.875 | 0,05% | Saham |
| Federation des caisses Desjardins du Quebec | $59.394 | 9.091 | 0,05% | Saham |
| Northwest & Ethical Investments L.P. | $41.050 | 6.237 | 0,03% | Saham |
| BlackRock, Inc. | $33.308 | 5.039 | 0,03% | Saham |
| Persistent Asset Partners Ltd | $25.059 | 3.791 | 0,02% | Saham |
| Beutel, Goodman & Co Ltd. | $23.806 | 3.627.864 | 0,02% | Saham |
| MORGAN STANLEY | $14.542 | 2.200 | 0,01% | Saham |
| TORONTO DOMINION BANK | $787 | 120 | 0,00% | Saham |
| INGALLS & SNYDER LLC | $452 | 68.450 | 0,00% | Saham |
| Caitong International Asset Management Co., Ltd | $344 | 52 | 0,00% | Saham |
| Quarry LP | $324 | 49 | 0,00% | Saham |
| NATIONAL BANK OF CANADA /FI/ | $36 | 8 | 0,00% | Saham |
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Joseph S. Freedman ×2 pengajuan | 16 Maret 2026 | 9,00% | Amandemen | — | SEC |
| Joseph S. Freedman (2) | 7 Nov. 2024 | — | Pengajuan awal | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.